Abstract:To analyze the risk factors of pediatric off-label drug use, and propose management strategies for policy making of the pediatric off-label drug use in China.(i) We applied stratified random sampling to select recipes of children aged 0 to 18 years in pediatric clinics and wards of the West China Second University Hospital in 2010. (ii) All included prescriptions were categorized as off-label use or on-label use, according to the latest package insert licensed by the State Food and Drug Administration. (iii) Risk factors and the weights were calculated using logistic regression. (iv) The correlation between risk factors and the different kinds of off-label prescriptions was presented using adjusted odds ratio, and the impact of the risk factors was measured using standardized partial regression coefficient. (v) SPSS 16.0 was used for statistic analysis. (vi) From the perspective of the medical institutions, pharmaceutical enterprises, professional institutions, and the public, we combined the results of the Evidence-based research on the policy of the off-label drug use in 15 countries and the results of risk factor analysis, in order to propose management strategies for the policy making of pediatric off-label drug use in China.(i) Using the method of sampling, we received 2640 recipes from outpatients and 14,374 prescriptions from 749 inpatients. (ii) The neonates (0 to 27 days) had higher risk in off-label drug use than the other three children age groups. (iii) The dermatological medicines (D), nervous system medicines (N), traditional Chinese medicines, and respiratory drugs (R) were high-risk off-label medicines whose labels should be updated more frequently. (iv) The great factors of off-label drug use are those influence health status and relate to health services (ICD-10:Z00-Z99) (mainly in the clinic of child care and growth development, and in the ward of chemotherapy). (v) Off-label drug use in the ward was 4.4 times than that in clinic service (P < 0.001), which suggested that off-label drug use in the ward may be a key point of the management of medical institutions. (vi) The risk of off-label essential drug use was 1.67 times than that of non-essential drug use. (vii) The risk of off-label Rx drug use was 3.2% higher than that of OTC (Over-The-Counter) drug use, without a significant difference.(i) A management guideline for off-label drug use is urgently needed, with which we can guide medical institutions to establish the management regulations of off-label drug use. (ii) Pediatric clinical research should be promoted actively, and pharmaceutical enterprises should be encouraged to completely provide pediatric drug information. (iv) Academic organizations should be invited to join in for best professional drug use. (v) Pediatric patients and their families should receive the education on rational drug use.

Off-label drug use in pediatric wards: a prospective study in a tertiary care hospital in Pune

Pediatric Off-Label and Unlicensed Drug Use and Its Implications

Off-label drug use in Psychiatry Outpatient Department: A prospective study at a Tertiary Care Teaching Hospital

A Survey of Off-label Drug Use Prescriptions in Pediatric Outpatient Department of West China Second University Hospital

Off-label drug use in outpatient children: A systematic review

Trends in Off-Label Drug Use in Ambulatory Settings: 2006–2015

Off-label use of antimicrobials among hospitalized children: a retrospective study of 3,406 patients

Off-label Drug Use in Hospitalized Children: A Systematic Review

Off‑label and unapproved pediatric drug utilization: A meta‑analysis

Use of Off-Label Nephrology-Related Drugs in Hospitalized Pediatric Patients: a Retrospective Study

Survey of unlicensed and off label drug use in paediatric wards in European countries

PAttern of drug use in PEdiatrics: An observational study in Italian hOSpitals (the PAPEOS study)

Analysis of Outpatient Off-label Use in the Third Hospital of Peking University

Pediatric off-label drug use in China: risk factors and management strategies.

Unlicensed/Off-Label Drug Prescriptions at Hospital Discharge in Children: An Observational Study Using Routinely Collected Health Data

The Use of Off-label and Unlicensed Drugs for Neonates: A Report from a Teaching Hospital in Baghdad

Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit

Recommendations on Off-Label Drug Use in Pediatric Guidelines

Off-label Oral-Antiepileptic Drugs Use in Inpatients of a Tertiary Pediatric Epileptic Center in China: a Cross Sectional Study

Current practice, management and awareness of pediatric off-label drug use in China-A questionnaire based cross-sectional survey